Diabetes Pharmacist : Diabetes Pharmacist Blog : Focus Express Mail Pharmacy : Insulin Pumps, Diabetes Supplies and Information

People with Type II Diabetes have a new treatment option with the approval of Tradjenta,a new once daily oral tablet.  "This approval provides another treatment option for the millions of Americans with type 2 diabetes," said Mary Parks, MD, director of the FDA's division of metabolism and endocrinology products. "It is effective when used alone or when added to existing treatment regimens."

In the same class as Januvia and Onglyza, Tradjenta comes in only ONE strength (5mg) and can be taken with other diabetes medications, like Glucophage (Metformin), Glimepiride (Amaryl),  and Pioglitazone (Actos).The drug is used in combination with diet and exercise and has been proven to be safe and effective in Type II Diabetics.
 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

A new drug  for both Type 1 and Type II diabetes,called Exsulin, is in the "pipeline" and could be sent to the FDA for approval in a few years.  Alexander Fleming, MD, former US Food and Drug Administration official and Exsulin Corp. Chief Medical Officer, said "the drug causes the cells in the pancreas to develop into insulin-secreting cells.This is actually a natural hormone we’re developing as a therapy.”  Exsulin will be injected like insulin, but it won't have any direct effect on blood sugar. 

For information on diabetes medications and diabetes testing supplies available at Focus Express Mail Pharmacy click here!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

A newly approved diabetes drug, Onglyza, is now available in U.S. pharmacies, effective Friday August 14, 2009.

Bristol Myers-Squibb and AstraZeneca PLC, which co-developed and will co-market the drug, said that Onglyza was approved as an adjunct to diet and exercise to improve blood-sugar control in adults for the treatment of type 2 diabetes mellitus.

It belongs to a class of drugs known as DPP-4 inhibitors, and will compete directly with the only other such drug on the market, Merck & Co.'s (MRK) Januvia, which has had the DPP-4 market to itself since it was introduced in 2006.

For more information on Onglyza go to http://www.onglyza.com/

Click here to learn more about diabetes medications available through Focus Express Mail Pharmacy!

• Email This
• Print
• Comments
• Trackbacks
• Share Link